Cleared Traditional

K111222 - MRI-Q SYSTEM

K111222 is an FDA 510(k) clearance for MRI-Q SYSTEM, manufactured by Resonance Health Analysis Services Pty, Ltd.. The device is a Class 2 Radiology device with product code LLZ cleared through the Traditional 510(k) pathway after a 87-day FDA review.

K111222 · Resonance Health Analysis Services Pty, Ltd. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2011
Decision
87d
Days
Class 2
Risk

K111222 is an FDA 510(k) clearance for the MRI-Q SYSTEM. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Resonance Health Analysis Services Pty, Ltd. (Irvine, US). The FDA issued a Cleared decision on July 28, 2011 after a review of 87 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Resonance Health Analysis Services Pty, Ltd. devices

FDA 510(k) Submission Details - K111222

510(k) Number K111222 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 02, 2011
Decision Date July 28, 2011
Days to Decision 87 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
20d faster than avg
Panel avg: 107d · This submission: 87d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LLZ Device Classification - Class 2, Special Controls

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1193
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K111222.
RADIOLOGICAL IMAGE PROCESSING SYSTEM
K102078 · VATECH Co., Ltd. · Aug 2011
IMPAX NEXT GENERATION
K111945 · Agfa Healthcare N.V. · Aug 2011
HEARTNAVIGATOR RELEASE 1
K111245 · Philips Medical Systems Nederland B.V. · Jul 2011
VITREAVIEW SOFTWARE 6.1
K111892 · Vital Images, Inc. · Jul 2011
IMPAX VOLUME VIEWING
K111638 · Agfa Healthcare N.V. · Jun 2011
QLAB 8.1 QUANTIFICATION SOFTWARE
K110414 · Philips Ultrasound, Inc. · Jun 2011